CCLCS program final.indd
Transcription
CCLCS program final.indd
CONFERENCE COLLABORATIVE CACMLE (Colorado Association for Continuing Medical Laboratory Education, Inc.) 6825 E. Tennessee Ave. Ste 111 Denver, Colorado 80224-1629 Phone: 303-321-1734 • Fax: 303-321-9231 email: info@CACMLE.org • Website: www.CACMLE.org Clinical Laboratory through COLLABORATION Permit No. 1203 Denver CO US POSTAGE PAID Non-Profit Org A Clinical Laboratory Continuing Education event organized by ASCLS-Colorado ASCLS-Wyoming CACMLE CLMA-Centennial Chapter May 13 – May 15, 2009 Schedule at a Glance Wednesday, May 13 7:30-8:30 Registration 8:00-9:00 Continental Breakfast 8:30-8:45 Opening ceremony and ASCLS-CO awards 8:45-9:45 Keynote 9:45–10:00 Break 10:00-11:30 Breakout Sessions 11:30-1:30 Lunch with Vendors 1:30-3:00 Breakout Sessions 3:00-3:15 Break 3:15-4:45 Breakout Sessions 4:45-5:00 P.A.C.E. Thursday, May 14 7:30-8:30 Registration 8:00-9:00 Continental Breakfast 8:30-8:45 Opening ceremony and ASCLS-WY awards 8:45-9:45 General Session 9:45-10:00 Break 10:00-11:30 Breakout Sessions 11:30-1:30 Lunch with Vendors 1:30-3:00 Breakout Sessions 3:00-3:15 Break 3:15-4:45 Breakout Sessions 4:45-5:00 P.A.C.E. Friday, May 15 7:30-8:30 Registration 8:00-9:00 Continental Breakfast 8:30-8:45 Opening Ceremony 8:45-9:45 General Session 9:45-10:00 Break 10:00-11:30 Breakout Sessions 11:30-1:30 Lunch with Vendors 1:30-3:00 Breakout Sessions 3:00-3:15 Break 3:15-4:45 Breakout Sessions 4:45-5:00 P.A.C.E. * Please bring this program to the conferrence ** Program schedule is tentative and subject to change Friday, May 15, 2009 • 1:30 - 3:00pm Come visit us online! • Prior to attending the session, attendees will need to print handouts by visiting us online at: www.clcconline.org A username and password is required for printing conference materials and will be provided with your registration confirmation. (Handouts will NOT be provided at the session.) • Directions and a map are available online. • Registration is available at www.clcconline.org and www.coclma.org and credit cards will be accepted. Session #25 Eeek! Newborn Differentials — Janet Oertli, MT(ASCP), CLS(NCA), Primary Children’s Medical Center This session presents pictures, pictures and more pictures from newborn peripheral blood smears, along with tips and tricks for identification of newborn blood cells. Case studies help tie it all together. Session #26 Fungal Cultures and Susceptibility Testing — Nancy Madinger, MD, University Hospital, Denver This session will address the changing epidemiology of fungal infections and review advances in rapid diagnostics and new products applicable to clinical microbiology. We will review antifungal drugs and evolving recommendations for antifungal susceptibility testing. Session #27 Blood Bank Case Studies — Monica LaSarre, MT(ASCP)SBB, Bonfils Blood Center The identification of a passively acquired red cell antibody can cause unique challenges for the blood bank. Consideration must be given to the source of the antibody, the appropriate reporting of the antibody (auto- vs. allo-), and the transfusion recommendations for an individual with such an antibody. A review of the history of Rh disease as well as Prenatal and ITP patient cases will be discussed. Friday, May 15, 2009 • 3:15 - 4:45pm Session #28 HbA1c Standardization to Screening? — Scott Joksch, Bio-Rad HbA1c method standardization has been achieved within United States. Screening for diabetics and pre-diabetics: Why use HbA1c in the screening process? What changes are needed to use HbA1c in the screening process and how will they impact your laboratory? Session #29 Molecular Diagnostics and Identification of Specific Pathogens — Hugh Maguire, PhD, Colorado Dept of Public Health and Environment Several methods will be described that are used during surveillance and outbreak investigation in the setting of a public health laboratory. How molecular techniques are employed during a rapid response or to create a genetic profile will be presented. The advantages and limitations will be addressed using specific examples of recent outbreaks. • CACMLE Annual Meeting, Wed, May 13, 5:00-7:00, with a special guest performance by Dr. Kevin Fitzgerald. Refreshments served. Room to be announced. • ASCLS-CO meeting, followed by IMSS planning committee meeting, Thursday, May 14, 5:00 - ?, room to be announced •ASCLS-WY meeting, Thursday, May 14, 5:00 - ?, room to be announced Session #30 The Evaluation and Management of Platelet Refractoriness — Kelley Capocelli, MD, University of Colorado Denver School of Medicine/The Children’s Hospital This talk represents an overview of the topic of platelet refractoriness, including discussion of assessing patient response to the platelet transfusion, the steps to take when concerns of platelet refractoriness arise and management of platelet transfusions in the setting of platelet refractoriness. Please visit with your vendors in the exhibits area each day. We are grateful for their continued support and want them to have the greatest opportunity to speak with their customers during this event. Session #16 Emerging Blood Transfusion Practices and Revitalization of the Hospital Transfusion Committee — Kathleen Houston, MT(ASCP)SBB, CQA(ASQ), The Children’s Hospital This session will discuss current initiatives to reduce unnecessary blood transfusions and to better manage precious blood resources. In addition, it will describe the AABB’s newly-launched Biovigilance Network for national tracking and trending of adverse transfusion-related events. Session #17 Diagnosis and Classification of AML Using the New WHO Classification —Sherrie Perkins, MD, PhD, ARUP This session will address the appropriate workup and diagnosis of AML using the new WHO guidelines. The session will examine the importance of morphology, immunophenotype, cytogenetics and molecular testing in making a diagnosis of AML. The session will also address the new impact of molecular testing on prognosis and treatment of AML. Thursday, May 14, 2009 • 3:15 - 4:45pm Session #18 Pulsed Field Gel Electrophoresis, PulseNet, and Foodborne Illness Epidemiology — Wanda Manley, MS, WY Public Health Laboratory A PowerPoint presentation that explains the use of PFGE and PulseNet in your public health labs to detect and track foodborne illness. We will talk about the PFGE process, introduce PulseNet, and talk about foodborne illness epidemiology during an outbreak. Session #19 Serum Free Light Chain Assay for Diagnosis and Monitoring of Multiple Myeloma and Other Monoclonal Gammopathies — Anne Sherwood, PhD, Binding Site The serum free light chain assay, FreeliteTM, is a highly specific, quantitative and fully automated approach to measure free lambda and kappa light chains in the serum. FreeliteTM provides a sensitive indicator of patient status in the diagnosis, treatment and remission of Multiple Myeloma and other B-cell dyscrasias. Concepts of the biology of free light chain processing in vivo as it affects test results in clinical samples will be presented and utilization of the free light chain assay and κ/λ free light chain ratios for risk stratification, diagnosis and monitoring of monoclonal gammopathies for patient management will be discussed using case studies. General Sessions Wednesday, May 13, 2009 Keynote Address • 8:45 - 9:45am Government Affairs Update — Linda Comeaux, CLS(NCA), Arapahoe Community College and Joe Miles, MHS, MT(ASCP), Frontline Laboratory Network Government Affairs activities by ASCLS and CLMA will be shared. Information about how the new Administration will impact the Clinical Laboratory legislative processes and any current legislative issues will also be discussed. Thursday, May 14, 2009 General Session • 8:45 - 9:45am Friday, May 15, 2009 • 10:00 - 11:30am Session #22 Vitamin D: Clinical Symptoms of Deficiency or Over Abundance — Ravinder Singh, PhD, Mayo Labs Dr Singh will present various methodologies for Vitamin D testing, recommendations of acceptable levels, and clinical cases of Vitamin D deficiency and overabundance. Session #23 Emerging Transfusion-Transmitted Diseases — Susan Epperson, MT(ASCP)SBB, Poudre Valley Hospital No session description available at time of printing Session #24 The Leadership Dilemma — JR Constance, MHA, MT(ASCP), CLCC There are many leadership styles, but not all of them are effective. What makes a good leader, and more importantly what is it about a leader that makes someone want to follow them? Attendees to this session will learn about various leadership styles, with a focus on the qualities of a good leader and what makes people want to follow them, and the tools that almost anyone can use to become that good leader. Session #11 Lessons Learned from Starbucks: Making ASCLS Extraordinary — Scott Aikey, MS, CLDir/CLS(NCA), President ASCLS The Starbucks Corporation has revolutionized the personalized customer experience model. Their five principles for turning ordinary into extraordinary to grow their business and customer base has direct application to ASCLS. This session will explore how ASCLS can take advantage of those lessons learned and apply them to our situation to grow our organization. Friday, May 15, 2009 • 8:45 - 9:45am Session #21 The Importance of Disease to Human Health — Gerald Callahan, PhD, Colorado State University Though routinely maligned, our diseases shape each of us from our births to our deaths. Seeing disease as a normal and essential part of human development can change the ways we think about health and health care. Session #20 Laboratory Compliance 101, Setting up a Laboratory Compliance Program — Theresa Mayer, MT(ASCP), CLS(NCA), Exempla Healthcare This session will discuss how a laboratory compliance program was set up for Exempla Healthcare. A short lecture on how the system was set up will be given followed by a Q&A session with questions submitted prior to the session. Please submit questions for the speaker by May 10, 2009, to:timjcathym@aol.com. Session #1 Hotel Information Red Lion Hotel Denver Southeast 3200 S. Parker Road Aurora, CO 80014 For Room Reservations call: 303-695-1700 or 800-962-7672 State you are part of the CLCC Discounted Conference Room Rate: $84/night Call by 4/21/09 to guarantee the discounted rate Directions to hotel available at www.clcconline.org Breakouts Wednesday, May 13, 2009 • 3:15 - 4:45pm Session #8 Disaster Contingency Planning — Tom Wachter, MBA/HCM, SLS(ASCP), ARUP Wednesday, May 13, 2009 • 10:00 - 11:30am Session #2 Interferon Gamma Release Assays (IGRAs) and Screening for MTB — Diane Weed, MA, MT(ASCP), Denver Health Medical Center This session will review the available tests for tuberculosis screening, including the new interferon gamma release assays (IGRAs). Session #3 Electrolyte Case Studies — Joan Polancic, MSEd, CLS(NCA), ASCLS Electrolyte test results are often difficult to explain due to their complicated regulation mechanisms (renal and hormonal). In this session, case studies will be used to guide the participants in understanding the usefulness of commonly used electrolyte tests, including sodium, potassium, chloride, bicarbonate, and magnesium. Causes, symptoms, and classification of disorders will be discussed. Beneficial resources that describe how the tests can be used for monitoring and treatment will be shared. Session #4 Clinical Significance, Detection and Identification of the D Antigen — Anna Loveless, MT(ASCP)SBB , Cheyenne Regional Medical Center This discussion will cover the history, clinical significance, and laboratory assays available to detect and identify D antigen and antibody. Wednesday, May 13, 2009 • 1:30 - 3:00pm Session #5 Applying the Quality System Essentials to a Quality System Model. How to Prepare a Quality Management Plan for your System — Nadine Alexander, MS, MT(ASCP), Memorial Hospital North, Colorado Springs This presentation will cover safety and quality issues from the entire hospital organization down to the lab. Patient safety and quality can be best addressed through a comprehensive, system wide quality management plan. Utilizing the CLSI’s 12 Quality System Essentials (QSE) as a framework and many of the policies and procedures already in place in our organizations, we are well on our way to forming a Quality Management Plan (QMP) that spans the entire path of workflow. Session #6 What’s the Scoop on Poop? An Update on Gastrointestinal Infections — Jay Lieberman, MD, Focus Diagnostics Gastrointestinal infections, caused by bacteria, viruses, and parasites, result in significant morbidity and mortality in the United States and globally. Clostridium difficile is a significant cause of hospitalacquired diarrhea, and the spread of a more virulent strain has led to cases, including severe disease, in populations classically not thought to be at risk. Unfortunately, the assays used commonly to detect C. difficile toxin are not sufficiently sensitive, and new antigen detection and molecular assays may play an increasingly important role in diagnostic testing. E. coli O157:H7 and other Shiga toxinproducing E. coli can lead to hemorrhagic colitis and hemolytic uremic syndrome. New recommendations will result in an increased likelihood of detecting these pathogens in patients with diarrhea. Among the most common viral causes of gastroenteritis are noroviruses and rotavirus. The use of a live, oral rotavirus vaccine in infants has led to marked declines in rotavirus disease in the U.S. Session #7 Why are Clinicians Requesting More and More Point of Care Testing in your Emergency Department? — Wendy Neil, RRT-NRP, Abbott Point of Care This session will address critical issues that Emergency Departments are facing. Additionally, how to improve Pre Analytical processes by bringing the lab to the patient. Lastly, we will review the impacts of rapid diagnosis and disposition of NSTEMI, heart failure, sepsis patients. This session will provide an overview of the disaster and contingency planning process for laboratory operations. Disaster and contingency planning are designed to ensure continued patient care in the event of a crisis affecting, or posing an imminent threat to, facility operations. This presentation will draw from the experience of a large single-site clinical testing laboratory, and will include practical “take home” ideas to prepare your own facility, administration and staff. Session #9 Monitoring Antithrombotic Therapy — George Fritsma, MS, MT(ASCP) Physicians have used the same anticoagulants, coumadin, and heparin, for at least 50 years. These drugs have saved countless lives. However they are dangerous, have a narrow therapeutic window, and require continuous laboratory monitoring. Since 1990, we have added safer forms of heparin, direct thrombin inhibitors, and anti-platelet drugs aspirin and clopidogrel. Now we await several new oral antithrombotics just emerging from clinical trials. Session #10 Lab Considerations for the Reproductive Endocrinologist — Kevin Bachus, MD, Rocky Mountain Center for Reproductive Medicine Through a format of didactic lecture, clinical case examples, and informal question and answer session, the speaker will discuss the most common clinical scenarios where the reproductive endocrinologist will require laboratory services in order to provide better patient care. Thursday, May 14, 2009 • 10:00 - 11:30am Session #12 The Electronic Health Record: Past, Present, Future, and the Impact on the Clinical Laboratory — Scott Aikey, MS, CLDir/CLS(NCA), CLCC This session will describe the drivers for change, which is leading to the implementation of electronic health record systems across the country. In addition, the attendee will be afforded the opportunity to view what a clinical electronic health record system looks like in use and how the laboratory component is integrated into the workflow. Ways in which laboratory professionals can get involved in the implementation and maintenance will also be discussed. Session #13 Celiac Disease: It’s More Than Just a Bad Stomach Ache — Ginger Weeden, CLS(NCA), MT(ASCP), Biorad Celiac disease has garnered more attention over the past several years since the offending antibodies have been identified and its relationship with other autoimmune disease and non-autoimmune diseases have been uncovered. Learn about the clinical laboratory tests used for diagnosis, the other tools that your physicians are using and what the consequences are of misdiagnosis or delayed diagnosis. Session #14 Myeloproliferative Neoplasms and the New WHO Classifications — Sherry Perkins, MD, PhD, ARUP Chronic myeloproliferative diseases are clonal hematologic neoplasms that are often difficult to accurately diagnose in the laboratory. This session will review changes in diagnosis and diagnostic approach to chronic myeloproliferative neoplasms according to the new WHO classification of hematologic neoplasms. The lecture will focus on clinical, morphologic and molecular features that are important in establishing a diagnosis. Thursday, May 14, 2009 • 1:30 - 3:00pm Session #15 Diagnosing Vaginal Infections with the Wet Prep Procedure —Teri Anderson, MT(ASCP), Denver Health This presentation will review the etiology as well as compare and contrast the clinical manifestations of trichomoniasis, candidiasis and bacterial vaginosis. Relevant laboratory and diagnostic procedures will be discussed.